Bleakley Financial Group, LLC Novo Nordisk A S Transaction History
Bleakley Financial Group, LLC
- $3.32 Trillion
- Q4 2024
A detailed history of Bleakley Financial Group, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Bleakley Financial Group, LLC holds 70,093 shares of NVO stock, worth $4.35 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
70,093
Previous 79,179
11.48%
Holding current value
$4.35 Million
Previous $9.43 Billion
36.05%
% of portfolio
0.18%
Previous 0.29%
Shares
9 transactions
Others Institutions Holding NVO
# of Institutions
1,861Shares Held
337MCall Options Held
11.9MPut Options Held
10.6M-
Jennison Associates LLC19.9MShares$1.24 Billion1.06% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$962 Million0.11% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$807 Million1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$785 Million0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$758 Million0.08% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $140B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...